tickstock newsroom AI
Articles
Tooru terminates proposed acquisition of Mylky
Tooru has pulled the plug on its planned purchase of Mylky after concluding the deal would have relied on significant new debt and exposed the group to unfamiliar European legal risk.
Clean Power Hydrogen suffers equipment damage in factory acceptance test
The AIM-listed developer of membrane-free electrolysers said the MFE220 1MW unit sustained significant damage during final Factory Acceptance Test at its Rossington facility, delaying completion and prompting a trading suspension while funding talks pause.
Drax commissions first OCGT at Hirwaun and assumes commercial control
"The successful commissioning of our first OCGT plant is a landmark moment for Drax," said Will Gardiner, Drax Group CEO.
AstraZeneca wins US approval for Imfinzi in early high‑risk bladder cancer
The FDA cleared Imfinzi (durvalumab) in combination with BCG for adult patients with BCG‑naïve, high‑risk non‑muscle‑invasive bladder cancer after the POTOMAC Phase III trial showed a 32% reduction in risk of recurrence, progression or death.
Mining Today: GreenX, Tungsten West, Great Western Mining, Cadence Minerals and more
A busy day for small-cap miners brought a significant resource estimate, a major earn-in deal, and fresh drilling results across the sector. GreenX Metals commanded attention after outlining a large Exploration Target at its Tannenberg copper-silver project in Germany.
Tech Today: IQE, Vesuvius, Cambridge Cognition, Defence Holdings
A busy session for London's technology names was dominated by IQE's twin announcements: an £81m fundraising that dilutes existing holders by a quarter, paired with upgraded revenue guidance of more than 20% growth for the full year.
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
A Phase 3 breakthrough in hepatitis B treatment dominated the health and biotech agenda, with GSK reporting functional cure rates that could surpass the current standard of care for the first time. Elsewhere, BSF Enterprise made headlines with a lab-grown "T-rex" leather handbag listed for auction.
Galantas Gold completes $100m funding for Chile mine projects
The AIM-quoted firm will fund exploration and development at the Indiana Gold and Copper Project and the Andacollo Gold Project in Chile.
Pets at Home tipped for upside as DB repeats Buy rating
DB sees the retail and vets company as a Buy, with a 230p price target.
Gresham House Energy Storage Fund signs SPAs for 297MW of battery projects
"We are hugely excited about the growth potential of the company over the next few years," said John Leggate CBE, Chair.
BSF Enterprise lists Lab‑Grown "T‑rex" leather handbag for auction at €500,000
Lab‑Grown Leather's flagship bio‑engineered 'T‑rex' leather handbag will be featured in Hôtel Drouot’s auction catalogue, with an official price estimate of €500,000.
Cambridge Cognition launches brain health study with Oura
The London-listed firm is partnering with Oura to run an IRB‑approved, large‑scale remote study that integrates its cognitive tests with continuous wearable data from Oura Ring wearable tech.
Frontier Developments announces launch date of Planet Zoo 2
The AIM-quoted video game developer will release Planet Zoo 2 on 13 October across all platforms - PC, PlayStation 5 and Xbox Series X|S - with the new title adding aquatic and flying species and a Wildlife Reserves conservation mode.
New Minnesota helium law derisks Pulsar Helium's Topaz project says analyst
SP Angel says Minnesota's new helium-specific permitting rules, plus Pulsar Helium's Jetstream appraisal results, materially de-risk the Topaz project and push the company toward production readiness.
Broker looks to restart catalysts with UK-mine developer Tungsten West tipped as a Buy
Zeus Capital has initiated coverage of Tungsten West with a Buy, backing the AIM-listed developer's Hemerdon restart while saying execution and the close of an up-to‑US$85m facility are the primary near‑term catalysts.
Greencore's upbeat first half earns Buy rating as margins improve
Johnson Matthey cash-flow surge signals its rework is working
eToro market analyst Mark Crouch says Johnson Matthey’s jump in free cash flow and recent disposals point to a credible shift toward cash generation, shareholder returns and clean‑tech growth.
SSE's capex surge can usher in a new growth era says stockbroker
"SSE charged to the top end of its full‑year earnings guidance," says Aarin Chiekrie, equity analyst at Hargreaves Lansdown, whilst arguing the utility is now entering a multi‑year growth phase.
GSK posts positive Phase 3 results for Hepatitis B treatment
“For the first time, bepirovirsen offers the possibility of significantly better functional cure rates than the current standard of care," said Tony Wood, GSK’s Chief Scientific Officer.
Cadence Minerals moves Azteca to contractor mobilisation
"With the LI granted, funding now progressing and contractor mobilisation expected to commence shortly, Azteca recommissioning is progressing rapidly into the execution phase," said Kiran Morzaria, Chief Executive Officer.